AdvanDx wins FDA clearance for new diagnostic test
According to AdvanDx, the EK/P aeruginosa PNA FISH is the first-ever test capable of identifying E coli and/or K pneumoniae and P aeruginosa directly from positive blood cultures
Voro Therapeutics and Alloy Therapeutics have formed a strategic research partnership to develop tumour-selective, next-generation masked T-cell engager (TCE) therapeutics.